XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Accumulated Other Comprehensive Loss
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard $ 57,205   $ 3,293   $ 53,912  
Beginning of period (in shares) at Mar. 31, 2017   173,106        
Beginning of the period at Mar. 31, 2017 856,111 $ 30,148 26,596 $ (174,037) 1,074,110 $ (100,706)
Beginning of the period (in shares) at Mar. 31, 2017       10,727    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 179,677       174,138 5,539
Purchase of registered shares (in shares)       581    
Purchases of registered shares (20,408)     $ (20,408)    
Sales of shares upon exercise of stock options and purchase rights 30,947   15,958 $ 14,989    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (1,126)    
Issuance of shares upon vesting of restricted stock units (25,505)   (40,402) $ 14,897    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,283)    
Share-based compensation 33,457   33,457      
Cash dividends ($0.63 per share) ($0.69 per share) (104,248)       (104,248)  
End of period (in shares) at Dec. 31, 2017   173,106        
End of the period at Dec. 31, 2017 1,007,236 $ 30,148 38,902 $ (164,559) 1,197,912 (95,167)
End of the period (in shares) at Dec. 31, 2017       8,899    
Increase (Decrease) in Shareholders' Equity            
Cumulative effect of adoption of new accounting standard $ (10,882)       (10,882)  
Beginning of period (in shares) at Mar. 31, 2018 173,106 173,106        
Beginning of the period at Mar. 31, 2018 $ 1,050,557 $ 30,148 47,234 $ (165,686) 1,232,316 (93,455)
Beginning of the period (in shares) at Mar. 31, 2018       8,527    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 210,614       215,452 (4,838)
Purchase of registered shares (in shares)       532    
Purchases of registered shares (22,454)     $ (22,454)    
Sales of shares upon exercise of stock options and purchase rights 10,135   6,008 $ 4,127    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (317)    
Issuance of shares upon vesting of restricted stock units (29,111)   (48,192) $ 19,081    
Issuance of shares upon vesting of restricted stock units (in shares)       (1,387)    
Share-based compensation 37,200   37,200      
Cash dividends ($0.63 per share) ($0.69 per share) $ (113,971)       (113,971)  
End of period (in shares) at Dec. 31, 2018 173,106 173,106        
End of the period at Dec. 31, 2018 $ 1,132,088 $ 30,148 $ 42,250 $ (164,932) $ 1,322,915 $ (98,293)
End of the period (in shares) at Dec. 31, 2018       7,355